Drugs / UIC202205
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06141590 | Mar → Aug 2023 | type 2 diabetes mellitus | Korea United Pharm. Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UIC202205 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06141590 ↗ |